Report
Jacob Mekhael ...
  • Thomas Vranken

Onward Medical € 50m equity raise from Ottobock and institutional investors

Last week, Onward announced an upsized € 50m capital increase, which included a € 22.5m ticket from Ottobock, a global player in the fields of prosthetics, orthotics and exoskeleton technology, as new cornerstone investor. The new shares were issued at € 5.00 p.s., representing a 12.6% discount vs. last closing price before deal announcement. We resume our coverage with a € 9.1 TP and Buy rating (from Suspended).
Underlying
ONWARD MEDICAL NV

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Jacob Mekhael

Thomas Vranken

Other Reports on these Companies
Other Reports from KBC Securities
Jacob Mekhael ... (+6)
  • Jacob Mekhael
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thomas Vranken
  • Wim Hoste

ResearchPool Subscriptions

Get the most out of your insights

Get in touch